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Abstract 
Background: Ethiopia is committed to improving access to human immunodeficiency virus (HIV) care and 
antiretroviral therapy (ART) service. In May 2005, some private hospitals in Addis Ababa City Administration 
received accreditation to provide ART services to eligible patients. 
Objective: To examine and describe the achievements of the ART Program in accredited private hospitals. 
Methods: Descriptive retrospective analyses of reported ART Program Data from accredited private hospitals, 
between May 2005 and 31st December 2009. The aggregate data was obtained from Addis Ababa Regional Health 
Bureau and consisted of information about patients enrolled for care, those who started ART, and those presently are 
on ART.  
Results: During the study period, 10,849 patients were enrolled for care, 9,442 who had just started ART and 5,608 
already on it across the study private facilities.   In general close to 75% of the total patients enrolled for care at five 
facilities. Although the majority (87%) had started treatment in the past, only 59.4% were currently on treatment. 
Overall, the program retained 66.4% of the patients (n=6,270) and attrition was 32% (n=3,021).  
Conclusions: Differences in patient enrollment for care, ART initiation and retention were observed across facilities.  
A significant number of patients discontinued treatment and their outcome status was unclear. A better monitoring and 
reporting of ART Program Data will improve program quality. An effective strategy is needed to enhance patient 




Human immunodeficiency virus (HIV) infection is a 
global public health problem. By the end of 2008, 33.4 
million people were infected with the virus worldwide 
(1). The majority (97%) of those infected were in low 
and middle-income countries, and 67% of these were in 
sub-Saharan Africa (2). In 2009, the prevalence of HIV 
in Ethiopia was 2.2% and 1.3 million people were living 
with HIV/AIDS (3).   
 
Anti-retroviral therapy (ART) reduces HIV replication, 
infection of new cells, and improves the immune system 
function (4), quality of life and survival (5). The World 
Health Organisation (WHO) guidelines recommend that 
adults and adolescents start treatment at an early stage of 
the disease (1). By December 2009, about 14.6 million 
people in low and middle-income countries required 
ART, but only 36% (5.25 million) of them received 
treatment, and 3.91 million of those were in sub-Saharan 
Africa (1). In Ethiopia, an estimated 336,160 people 
required ART in 2009 (3). 
 
The Ethiopian Government is committed to universal 
access to safe, comprehensive care and treatment by the 
end of 2010 (6). Following the implementation of the 
WHO public health approach in 2005, the number of 
facilities providing ART service and patients receiving 
treatment has increased (7). In 2005, the Government and 
partners started ART (8). The Government Policy on 
antiretroviral (ARV) drugs has also encouraged 
international initiatives on ARVs (9). Free ARV service 
was launched in January 2005 and public hospitals 
started providing free ARVs in March 2005 (10).  By 
February 2010, the number of people who were ever 
enrolled, ever started and currently on treatment in the 
country had increased to 443,964, 246,347 and 179,183, 
respectively (11).  
 
After 2005, HIV care and ART services were further 
decentralized in Ethiopia. Private hospitals (12) and 
health centers started delivering ART and HIV care in 
June 2006 (9,10). This was in line with several African 
countries that adopted the private and public health 
approach to scale up access to ART, provide care and 
treatment to HIV/AIDS patients (13). In the Addis Ababa 
Region, the public-private partnership commenced in 
2005 and private hospitals were later accredited to 
provide ART services (14). To date, only one study has 
examined the quality of ART services in governmental 
hospitals in the Addis Ababa Region (15) and none in the 
accredited private hospitals. This study examined the 
accomplishment of ART programs in accredited private 
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hospitals in Addis Ababa City Administration (AACA), 
including patient retention and attrition.   
 
Methods 
We did a retrospective analysis of reported ART Program 
Data from accredited private hospitals in AACA from 1st 
May 2005 to 31st December 2009. The aggregate data 
was obtained from the Addis Ababa Regional Health 
Bureau (AARHB) and contained names of accredited 
private hospitals, total patients enrolled for care, those 
who started ART, currently on ART and follow-up 
status. We did not attempt to establish how the study 
facilities compile data or report their ART Program Data 
to the AARHB. The study totally depended on data 
available at the AARHB.  The pre-ART estimate refers to 
patients who were enrolled for HIV/AIDs care, but did 
not start treatment, and was calculated for each facility 
by subtracting those who started ART from those 
enrolled for care. The operational definitions of the 
outcome of patients on ART was categorized as: 
transferred out (patients transferred to other facilities and 
assumed retained); transferred in (transferred out from 
other facilities and accepted); lost (not seen for one 
month or more and to less than three months); dropped 
out (lost to follow up for three months or more); stopped 
(still receiving care, but stopped ART treatment); and 
dead. We defined patient retention as being currently on 
ART or transferred out to another facility, and attrition as 
died, lost, dropped out or stopped treatment. The ART 
Program Data were summarized using percentages, 
median and inter-quartile (25th–75th percentile) range 
[median (IQR)]. The Win PEPI software for Windows (V 
2.17) was used for descriptive statistics (16). 
 
Results 
From 1st May 2005 to 31st December 2009, a total of 
10,849 patients were enrolled for HIV/AIDS care, 9,442 
started ART and 5,608 were currently on treatment at 16 
accredited private hospitals in AACA (Table 1). The 
follow up status of 2,927 patients not currently on ART 
was also documented and reported (Table 2). At the time 
the ART Program Data was obtained from the AARHB, 
the MMD General and Nazrawi Hospitals had terminated 
their ART programs. The MMD General Hospital was 
sold and renamed St. Yared General Hospital. The 
outcome of HIV/AIDS patients enrolled at the MMD was 
unknown and their records were not transferred to the 
new St. Yared General Hospital. 
 
Table 1: Number and percent of patients ever enrolled for care, ever started ART and currently on ART 





Ever enrolled  
for care 
Ever started ART Currently on ART Pre-ART  
estimate‡ 
n (%) n (%) n (%) n (%) 
Addis General Addis ketema 1,332 (12.3) 873 (66) 371 (43) 459 (33) 
Ethio-Tebib Addis ketema 227 (2.1) 221 (97.4) 145 (66) 6 (0.4) 
Girum Addis ketema 23 (0.2) 17 (74) 23* 6 (0.4) 
Zenbaba general Akaki kality 1,581 (15) 1,470 (93) 822 (56) 111 (8) 
Tibebu General Arada 429 (4) 411 (96) 280 (68) 18 (1.3) 
Nazrawi General** Arada 4 (0.04) 3 (75) 3 (100) 1 (0.1) 
St. Gebreal Bole 773 (7) 737 (95.3) 362 (49) 36 (3) 
MMD Generalƒ Bole 198 (2) 163 (82.3) 74 (45.4) 35 (3) 
HAYAT Bole 1,192 (11) 1,044 (88) 612 (59) 148 (11) 
Myungsung Christian  
Medical Centre (MCM) Bole 810 (8) 584 (72) 374 (64) 226 (16) 
St.Yared General Bole 22 (0.2) 20 (91) 17 (85) 2 (0.14) 
Bethezatha general Kirkose 2,788 (26) 2,558 (92) 1,712 (67) 230 (16.3) 
Land Mark Kirkose 25 (0.23) 24 (96) 23 (96) 1 (0.07) 
Bethel Kolfae 1,179 (11) 1,086 (92) 631 (58) 93 (7) 
TZNA general Ledeta 182 (2) 153 (84) 104 (68) 29 (2) 
National Yeka 84 (1) 78 (93) 55 (71) 6 (0.4) 
Total 10,849 (100) 9,442 (87) 5,608 (59.4) 1,407 (100) 
‡Enrolled for care but didn’t start (ever enrolled minus ever started ART)  
* Greater than the reported number of patient who ever started ART (n=17) 
** Terminated ART program    ƒ Sold and renamed St Yared General. 
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Table 2: Follow up status and characteristics of patients who attended ART program at accredited private hospitals in Addis Ababa Region (May 2005-31st Dec 2009) 
Private hospital 
Ever started 
ART but not 
currently on 
ART** 
Follow up status of 














Reported Not reportedƒ Reported 
Not 
reportedƒ 
Addis General 502 132 370 371 13 3 370 21 3 80 384 (44) 477 (55) 
Ethio-Tebib 76 20 56 145 4 3 56 2 0 8 149 (67.4) 69 (31) 
Girum 0 2*  23‡ 0 1  0 0 1 23 (100) 2 (12) 
Zenbaba 648 623 25 822 144 3 25 371 0 27 966 (66) 426 (29) 
Tibebu General 131 222*  280 53 1  100 2 19 333 (81) 122 (30) 
Nazrawi General 0# 0 0 3 0 0 0 0 0 0 3 (100) 0 (0) 
St. Gebreal 375 337 38 362 75 0 38 211 5 32 437 (59) 286 (39) 
MMD General 89 80 9 74 49 0 9 22 0 6 123 (76) 37 (23) 




210 127 83 374 42 2 83 33 9 35 416 (71) 162 (28) 
St.Yared General 3 5*  17 0 0  1 0 3 17 (85) 4 (20) 
Bethezatha 846 508 338 1,712 160 16 338 233 3 36 1,872 (73) 626 (25) 
Land Mark 1 0 1 23 0 0 1 0 0 0 23 (96) 1 (4) 
Bethel 455 481*  631 62 0  369 0 14 693 (64) 383 (35) 
TZNA 49 9 40 104 2 0 40 0 2 1 106 (69) 43 (28) 
National 23 0 23 55 0 0 23 0 0 0 55 (71) 23 (30) 
Total 3,840 2,927 1,034 5,608 662 35 1,034 1,654 24 274 6,270 (66.4) 3,021 (32) 
** Estimated from Table 1 (ever started ART minus those currently on ART). 
ƒ Not reported but estimated and assumed lost 
ƒƒ Sum of those currently on ART and transferred out to another facility. 
§ Includes lost, dropped out, stopped treatment and died. 
* Number greater than those who started but not on ART. 
‡ Reported 23 patients currently on ART incompatible with the reported number of patients ever started ART (n=17). 
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The median (IQR) number of patients enrolled for 
HIV/AIDS care at 16 private facilities during the study 
period was 328 (54.5-1,185.5). The lowest number of 
patient enrollment was at Nazrawi (n=4) and the highest 
at Bethezatha (n=2,788). Patient enrolments for care at 
five hospitals (Bethezatha, Bethel, Zenbaba, Hayat, Addis 
General) accounted for 74.5% of the total enrolments 
during the study period (Table 1). 
 
The majority (87%, n=9,442) of patients who enrolled for 
care started ART treatment. Conversely, ART initiation 
varied across hospitals ranging from 66% in Addis 
General to 97.4% of patients in Ethio-Tebib Hospital. The 
median (IQR) number of patients who initiated ART was 
316 (51-958.5). Collectively, patients commencing ART 
from four hospitals (Zenbaba, Bethezatha, Hayat, Bethel) 
accounted for 65.3% of the total who had started ART at 
all private facilities.  
 
About 59.4% of patients (n=5,608) who ever started ART 
were currently on ART. However, this varied across 
hospitals ranging from 43% (Addis General) to 100% 
(Girum, Nazrawi). The median (IQR) number of patients 
currently on ART was 212 (39-493). Approximately, 
67.4% of those patients were from four hospitals 
(Bethezatha, Zenbaba, Bethel, Hayat).  
 
The pre-ART estimate for the private facilities is shown 
in Table 1. Generally, a total of 1,407 (13%) patients had 
contact with pre-ART care at the facilities. Although 
these patients have enrolled for care, they did not start 
ART treatment and may represent the pre-ART estimate 
at the study facilities during the study period. The median 
(IQR) number of patients who had contact with pre-ART 
care at private hospitals was 32 (6-130).  
 
Among 9,442 patients who had started treatment, 3,834 
(41%) were not currently on treatment (Table 2), and the 
follow up outcome status was documented and known 
only for 2,927 of the patients, but not for the remaining 
907 patients. Conversely, our estimate showed the 
number of patients on ART and with unknown outcome 
status being 1,034 and not 907 as recorded in the data 
obtained from the AARHB. Thus, we assumed that 1,034 
patients were lost and added them to the 35 patients 
officially reported as lost. As a result, the total number of 
patients lost was 1,069 and not 35. The total attrition from 
ART treatment in the facilities was therefore, estimated to 
be 32% during the study period. The causes of attrition 
were drop out (55%), lost (35.4%), death (9%), and 
stopping treatment (0.8%). 
 
Of 2,927 patients with known follow up status, 1,654 
(57%) were labeled as dropped out, 662 (23%) transferred 
out to another facility, 278 (10%) transferred in, 274 
(9.4%) dead, 35 (1.2%) lost, and 24 (0.82%) stopped 
treatment. Collectively, 89.1% of the total drop outs were 
from Zenbaba, St Gebreal, Hayat, Bethezatha, and Bethel 
Hospitals. Likewise, patients’ death from Addis General, 
St Gebreal, Myungsung Christian Medical Centre 
(MCM), Bethezatha and Zenbaba Hospitals accounted for 
77% of the total deaths (data not shown). 
 
Considering those who were currently on ART (n=5,608) 
and transferred out to another facility, (n=662), the 
private hospitals had retained 66.4% of their patients 
during the study period (Table 2). However, retention 
varied across hospitals, ranging from 100% (Girum, 
Nazrawi) to 44% (Addis General). The median (IQR) 
retention was 71% (65.1% - 83%). Hospitals like 
Bethezatha, Zenbaba, Bethel, and Hayat, which had 
enrolled several patients for ART, had retention below 
74%, whereas hospitals with fewer than 25 patients 
enrolled for ART showed over 85% retention. 
 
Discussion 
This descriptive retrospective review of ART Program 
Data from 16 accredited private hospitals in AACA, 
found differences in the number of patients enrolled for 
care, those who started ART and currently on treatment 
across the facilities. Possible reasons for the difference 
could be that some of the hospitals are more accessible 
and have more resources to cope with more patients of 
the locality in need of ART. 
 
The total pre-ART estimate for the study facilities was 
13% (n=1,407) and those patients did not start treatment 
despite enrolling for pre-ART care. This may reflect that 
the pre-ART program in some facilities is not effective in 
retaining patients after they sign up for care. Hence, 
evaluation of the effectiveness of pre-ART program in 
these facilities is crucial.   
 
The overall patient retention in ART program in 
accredited private hospitals was 66.4%. This is lower than 
the 75.1% national average retention (8), 67% in South 
Africa (17), 72% in Uganda (18) and 82% average 
retention rate across low and middle-income countries 
(1). Patient retention in ART programs in service delivery 
settings in sub-Saharan Africa showed retention of 86.1% 
at 6 months and 80.2% at 12 months (19). It is 
noteworthy that in this study, private hospitals with fewer 
patient enrolments showed better retention. There are two 
possible explanations for this: It is generally true that for 
hospitals enrolling relatively fewer patients, it is easier to 
follow-up or retain them than hospitals enrolling many 
patients. Possibly, those hospitals may also have effective 
strategy to retain and trace patients following enrolling 
for care.  Patient retention in ART programs is not only a 
major problem in private hospitals in Addis Ababa, but 
also a serious concern in many countries of sub-Saharan 
Africa (13, 20-22). Hence, it is necessary to regularly 
review and improve the effectiveness of the strategies to 
retain and follow patients post enrolment. 
 
Estimating patient attrition in the study facilities was not 
straightforward because of lack of accurate and complete 
data. After adjustments to the reported data, attrition from 
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treatment was estimated to be as 32%. Drop out and lost 
accounted for 55% and 35.4% of attrition, respectively. 
Although our attrition figure (32%) falls within the 
attrition range reported by the HIV/AIDS Prevention and 
Control Office (HAPCO) for the regions (18.1% for 
Harari and 36% Gambela), it was higher than the national 
average of 24.9% (8).  A study in Jimma University 
specialized hospital showed a significant number of 
patients defaulted from ART treatment for several reasons 
including, loss of hope in medication, lack of food, 
mental illness, holy water treatment, and being unable to 
pay for transport (23). 
  
High rate of attrition from ART programs may pose a 
serious challenge (20). To minimize attrition from ART 
care, the study facilities needed to follow up all patients 
methodically and accurately record their status after 
initiating treatment. In our analysis, we found patients 
who were unaccounted for and those whose follow up 
status was unclear.  Those patients attended Addis 
General, Bethezatha, Hayat, Myungsung Christian 
Medical Centre (MCM), Ethio-Tebib, TZNA, or St 
Gebreal hospitals. We believe that those patients could 
have been traced and retained in the ART care if there 
were effective monitoring and follow-up procedures.  
 
Our study had strengths and limitations. We used the 
available ART Program Data and no additional funding 
or resources to conduct the study.  The study was the first 
to be done since accredited private hospitals started 
providing ART services in AACA. However, there were 
limitations to the study. First, it was a descriptive 
retrospective study based on publicly available aggregate 
ART Program Data routinely collected by the AARHB. 
We did not attempt to verify how the study facilities 
compiled and reported their ART Program Data. As a 
result, it was difficult to comment about data quality in 
the facilities. The private facilities might have also some 
data that is fairly well- documented, but did not report to 
the AARHB. Secondly, the study focused on process 
evaluation and not on impact evaluation of the ART 
program in the study facilities. The ART Program Data 
was not evaluated in relation to targets set for each private 
hospital. We also did not look into the study hospitals to 
check their data recording and if they had not reported 
some data to the AARHB. Our analysis did not examine 
the characteristics of ART patients because our selection 
and reporting of outcomes was dictated by the accessible 
data set obtained from the AARHB. Similarly, the 
estimated attrition and retention rates do not add up to 
100 percent and reflects either poor data recording or 
reporting in some of the study facilities. 
 
The ART service in accredited private hospitals is part of 
the 2003 national program and was introduced in 2005 to 
provide comprehensive care to eligible patients residing 
in AACA. We acknowledge that these facilities are 
playing a significant role in improving access and 
delivering ART to patients. To improve the quality of 
ART Program Data from accredited private hospitals to 
the AARHB, we think more in-depth study of the ART 
data in each facility is warranted to establish what data 
they are recording, reporting or not reporting to the 
AARHB. Our findings also indicate the need for better 
and periodic auditing of ART programs, including patient 
retention, data quality and reporting in these facilities. 
Likewise, this study raises other valid questions for 
further research: Why some facilities are enrolling more 
patients than others? What are the socio-demographic and 
clinical features of patients enrolled in the HIV care and 
treatment? Does the ART program at the private facilities 
have an impact on patient health outcome such as quality 
of life or mortality? What major factors (hospital or 
patient-related) are associated with different treatment 
outcomes? How can the gap between patients who started 
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